메뉴 건너뛰기




Volumn 11, Issue 8, 2016, Pages

99mTc labeled glucagon-like peptide-1-analogue (99mTc-GLP1) scintigraphy in the management of patients with occult insulinoma

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE TC 99M; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INSULIN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG; [LYSINE 40[AHX HYNIC EDDA]NH2] EXENDIN 4 TC 99M; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; PEPTIDE; TECHNETIUM COMPLEX; VENOM;

EID: 84984850895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160714     Document Type: Article
Times cited : (31)

References (35)
  • 1
    • 62349118969 scopus 로고    scopus 로고
    • Evaluation and management of adult hypoglycemic disorders: An endocrine society clinical practice guideline
    • 19088155
    • Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009; 94:709-728 doi: 10.1210/jc.2008-1410 PMID: 19088155
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 709-728
    • Cryer, P.E.1    Axelrod, L.2    Grossman, A.B.3    Heller, S.R.4    Montori, V.M.5    Seaquist, E.R.6
  • 2
    • 0001720558 scopus 로고
    • The surgical therapy of hyperinsulinism
    • Whipple AO 1938 The surgical therapy of hyperinsulinism.J Int Chir 3:237-276
    • (1938) J Int Chir , vol.3 , pp. 237-276
    • Whipple, A.O.1
  • 3
    • 62349142467 scopus 로고    scopus 로고
    • Glucose homeostasis and hypoglycemia
    • Kronenberg H, Melmed S, Polonsky K, Larsen P, eds 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc
    • Cryer P 2008 Glucose homeostasis and hypoglycemia. In: Kronenberg H, Melmed S, Polonsky K, Larsen P, eds. Williams textbook of endocrinology, 11th ed. Philadelphia: Saunders, an imprint of Elsevier, Inc.; 1503-1533
    • (2008) Williams Textbook of Endocrinology , pp. 1503-1533
    • Cryer, P.1
  • 4
    • 42149161294 scopus 로고    scopus 로고
    • Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: Hypoglycaemia unawareness and attacks
    • Christesen HB, Brusgaard K, Beck Nielsen H, Brock Jacobsen B. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks. Clin Endocrinol 2008; 68:747-755
    • (2008) Clin Endocrinol , vol.68 , pp. 747-755
    • Christesen, H.B.1    Brusgaard, K.2    Beck Nielsen, H.3    Brock Jacobsen, B.4
  • 6
    • 33846536315 scopus 로고    scopus 로고
    • Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: A diagnostic and therapeutic challenge
    • 17263973
    • Raffel A, Krausch MM, Anlauf M, Wieben D, Braunstein S, Klöppel G, et al. Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery. 2007; 141:179-184 PMID: 17263973
    • (2007) Surgery. , vol.141 , pp. 179-184
    • Raffel, A.1    Krausch, M.M.2    Anlauf, M.3    Wieben, D.4    Braunstein, S.5    Klöppel, G.6
  • 8
    • 0025834711 scopus 로고
    • Functioning insulinoma - Incidence, recurrence, and long-term survival of patients: A 60-year study
    • 1677058
    • Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma - incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66:711-719 PMID: 1677058
    • (1991) Mayo Clin Proc , vol.66 , pp. 711-719
    • Service, F.J.1    McMahon, M.M.2    O'Brien, P.C.3    Ballard, D.J.4
  • 9
    • 65249139010 scopus 로고    scopus 로고
    • Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007
    • 19141587
    • Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009; 94:1069-1073 doi: 10.1210/jc.2008-2031 PMID: 19141587
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 1069-1073
    • Placzkowski, K.A.1    Vella, A.2    Thompson, G.B.3    Grant, C.S.4    Reading, C.C.5    Charboneau, J.W.6
  • 10
    • 84976498082 scopus 로고    scopus 로고
    • Endoscopic ultrasound in endocrinology: Imaging of the adrenals and the endocrine pancreas
    • 27003412
    • Kann PH. Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas. Front Horm Res. 2016; 45:46-54 doi: 10.1159/000442277 PMID: 27003412
    • (2016) Front Horm Res. , vol.45 , pp. 46-54
    • Kann, P.H.1
  • 11
    • 84962606474 scopus 로고    scopus 로고
    • Preoperative localization of an insulinoma: Selective arterial calcium stimulation test performance
    • 26577133
    • Morera J, Guillaume A, Courtheoux P, Palazzo L, Rod A, Joubert M, et al. Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance. J Endocrinol Invest. 2016; 39:455-463 doi: 10.1007/s40618-015-0406-4 PMID: 26577133
    • (2016) J Endocrinol Invest. , vol.39 , pp. 455-463
    • Morera, J.1    Guillaume, A.2    Courtheoux, P.3    Palazzo, L.4    Rod, A.5    Joubert, M.6
  • 12
    • 57349195981 scopus 로고    scopus 로고
    • Peptide-based probes for cancer imaging
    • 18927341
    • Reubi JC, Maecke HR. Peptide-Based Probes for Cancer Imaging. J Nucl Med. 2008; 49:1735-1738 doi: 10.2967/jnumed.108.053041 PMID: 18927341
    • (2008) J Nucl Med. , vol.49 , pp. 1735-1738
    • Reubi, J.C.1    Maecke, H.R.2
  • 13
    • 84455199744 scopus 로고    scopus 로고
    • Repeated cycles of peptide receptor radiobuclide therapy (PRRT)-Results and side-effects of the radioisotope 90YDOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA-TATE therapy in patients with disseminated NET
    • 21885142
    • Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefanska A, et al. Repeated cycles of peptide receptor radiobuclide therapy (PRRT)-Results and side-effects of the radioisotope 90YDOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA-TATE therapy in patients with disseminated NET. Radiother Oncol. 2011; 102:45-50. doi: 10.1016/j.radonc.2011.08.006 PMID: 21885142
    • (2011) Radiother Oncol. , vol.102 , pp. 45-50
    • Pach, D.1    Sowa-Staszczak, A.2    Kunikowska, J.3    Królicki, L.4    Trofimiuk, M.5    Stefanska, A.6
  • 14
    • 77956183469 scopus 로고    scopus 로고
    • PET radiopharmaceuticals in radiation treatment planning - Synthesis and biological characteristics
    • 20724013
    • Haubner R. PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. Radiother Oncol. 2010; 96:280-287. doi: 10.1016/j.radonc.2010.07.022 PMID: 20724013
    • (2010) Radiother Oncol. , vol.96 , pp. 280-287
    • Haubner, R.1
  • 15
    • 84905024052 scopus 로고    scopus 로고
    • Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors
    • 24458014
    • Toumpanakis C, Kim MK, Rinke A, Bergestuen DS, Thirlwell C, Khan MS, et al. Combination of Cross-Sectional and Molecular Imaging Studies in the Localization of Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2014; 99:63-74 doi: 10.1159/000358727 PMID: 24458014
    • (2014) Neuroendocrinology. , vol.99 , pp. 63-74
    • Toumpanakis, C.1    Kim, M.K.2    Rinke, A.3    Bergestuen, D.S.4    Thirlwell, C.5    Khan, M.S.6
  • 17
    • 0037907532 scopus 로고    scopus 로고
    • Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting
    • 12707737
    • Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging. 2003; 30:781-793 PMID: 12707737
    • (2003) Eur J Nucl Med Mol Imaging. , vol.30 , pp. 781-793
    • Reubi, J.C.1    Waser, B.2
  • 18
    • 0029117847 scopus 로고
    • Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas
    • 7646446
    • Widmann Ch, Dolci W, Thorens B. Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochem J. 1995; 310:203-214 PMID: 7646446
    • (1995) Biochem J. , vol.310 , pp. 203-214
    • Widmann, C.H.1    Dolci, W.2    Thorens, B.3
  • 19
    • 49449085799 scopus 로고    scopus 로고
    • Glucagon-like peptide 1-receptor scans to localize occult insulinomas
    • 18703486
    • Wild D, Mäcke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med. 2008; 359:766-768. doi: 10.1056/NEJMc0802045 PMID: 18703486
    • (2008) N Engl J Med. , vol.359 , pp. 766-768
    • Wild, D.1    Mäcke, H.2    Christ, E.3    Gloor, B.4    Reubi, J.C.5
  • 20
    • 70449111654 scopus 로고    scopus 로고
    • Glucagon-like peptide 1-receptor imaging to localization of insulinomas
    • 19820010
    • Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, et al. Glucagon-like peptide 1-receptor imaging to localization of insulinomas. J Clin Endocrinol Metab. 2009; 94:4398-4405. doi: 10.1210/jc.2009-1082 PMID: 19820010
    • (2009) J Clin Endocrinol Metab. , vol.94 , pp. 4398-4405
    • Christ, E.1    Wild, D.2    Forrer, F.3    Brändle, M.4    Sahli, R.5    Clerici, T.6
  • 21
    • 84884502687 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor imaging for the localization of insulinomas: A prospective multicentre imaging study
    • 24622317
    • Christ E, Wild D, Ederer S, Béhé M, Nicolas G, Caplin ME, et al. Glucagon-like peptide-1 receptor imaging for the localization of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013; 1:115-122 doi: 10.1016/S2213-8587(13)70049-4 PMID: 24622317
    • (2013) Lancet Diabetes Endocrinol. , vol.1 , pp. 115-122
    • Christ, E.1    Wild, D.2    Ederer, S.3    Béhé, M.4    Nicolas, G.5    Caplin, M.E.6
  • 22
    • 79960296365 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
    • 21680696
    • Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brändle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-1078 doi: 10.2967/jnumed.110.085142 PMID: 21680696
    • (2011) J Nucl Med , vol.52 , pp. 1073-1078
    • Wild, D.1    Christ, E.2    Caplin, M.E.3    Kurzawinski, T.R.4    Forrer, F.5    Brändle, M.6
  • 23
    • 84899991622 scopus 로고    scopus 로고
    • Detection of metastatic insulinoma by positron emission tomography with [(68)Ga]exendin-4 - A case report
    • 24512490
    • Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, et al. Detection of metastatic insulinoma by positron emission tomography with [(68)Ga]exendin-4 - a case report. J Clin Endocrinol Metab. 2014; 99:1519-1524 doi: 10.1210/jc.2013-3541 PMID: 24512490
    • (2014) J Clin Endocrinol Metab. , vol.99 , pp. 1519-1524
    • Eriksson, O.1    Velikyan, I.2    Selvaraju, R.K.3    Kandeel, F.4    Johansson, L.5    Antoni, G.6
  • 24
    • 77954986457 scopus 로고    scopus 로고
    • Exendin-4 based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT
    • 20595511
    • Wild D, Wicki A, Mansi R, Béhé M, Keil B, Bernhardt P, et al. Exendin-4 based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 2010; 51:1059-1067 doi: 10.2967/jnumed.110.074914 PMID: 20595511
    • (2010) J Nucl Med , vol.51 , pp. 1059-1067
    • Wild, D.1    Wicki, A.2    Mansi, R.3    Béhé, M.4    Keil, B.5    Bernhardt, P.6
  • 26
    • 14844329847 scopus 로고    scopus 로고
    • Imaging and localization of islet-cell tumours of the pancreas on CT and MRI
    • 15763695
    • Noone TC, Hosey J, Firat Z, Semelka RC. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab. 2005; 19:195-211. PMID: 15763695
    • (2005) Best Pract Res Clin Endocrinol Metab. , vol.19 , pp. 195-211
    • Noone, T.C.1    Hosey, J.2    Firat, Z.3    Semelka, R.C.4
  • 28
    • 0036959991 scopus 로고    scopus 로고
    • Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
    • 11889194
    • Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, et al. Effects of Glucagon-Like Peptide 1 on counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers. J Clin Endocrinol Metab. 2002; 87:1239-1246 PMID: 11889194
    • (2002) J Clin Endocrinol Metab. , vol.87 , pp. 1239-1246
    • Nauck, M.A.1    Heimesaat, M.M.2    Behle, K.3    Holst, J.J.4    Nauck, M.S.5    Ritzel, R.6
  • 29
    • 0027248866 scopus 로고
    • Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
    • 8405741
    • Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 1993; 36:741-744 PMID: 8405741
    • (1993) Diabetologia , vol.36 , pp. 741-744
    • Nauck, M.A.1    Kleine, N.2    Orskov, C.3    Holst, J.J.4    Willms, B.5    Creutzfeldt, W.6
  • 30
    • 0030613750 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 and its potential in the treatment of non-insulindependent diabetes mellitus
    • 9370106
    • Nauck MA, Holst JJ, Willms B. Glucagon-like peptide 1 and its potential in the treatment of non-insulindependent diabetes mellitus. Horm Metab Res. 1997; 29:411-416 PMID: 9370106
    • (1997) Horm Metab Res. , vol.29 , pp. 411-416
    • Nauck, M.A.1    Holst, J.J.2    Willms, B.3
  • 31
    • 0030667056 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
    • 9374685
    • Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997; 273: E981-E988 PMID: 9374685
    • (1997) Am J Physiol. , vol.273 , pp. E981-E988
    • Nauck, M.A.1    Niedereichholz, U.2    Ettler, R.3    Holst, J.J.4    Orskov, C.5    Ritzel, R.6
  • 32
    • 0030068620 scopus 로고    scopus 로고
    • Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
    • 8550773
    • Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA, Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81:327-332 PMID 8550773.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 327-332
    • Willms, B.1    Werner, J.2    Holst, J.J.3    Orskov, C.4    Creutzfeldt, W.5    Nauck, M.A.6
  • 33
    • 69949115448 scopus 로고    scopus 로고
    • No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects
    • Lerche S, Soendergaard L, Rungby J, Moeller N, Holst JJ, Schmitz OE, et al. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrin. 2009; 71:500-506
    • (2009) Clin Endocrin. , vol.71 , pp. 500-506
    • Lerche, S.1    Soendergaard, L.2    Rungby, J.3    Moeller, N.4    Holst, J.J.5    Schmitz, O.E.6
  • 34
    • 12844251849 scopus 로고    scopus 로고
    • Focal and diffuse forms of congenital hyperinsulinism: The keys for differential diagnosis
    • 15640550
    • Sempoux C, Guiot Y, Jaubert F, Rahier J.Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol. 2004; 15:241-246 PMID: 15640550
    • (2004) Endocr Pathol. , vol.15 , pp. 241-246
    • Sempoux, C.1    Guiot, Y.2    Jaubert, F.3    Rahier, J.4
  • 35
    • 34147154971 scopus 로고    scopus 로고
    • Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or betacell hyperplasia in adult patients
    • 17227804, 1237-1244
    • Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, et al. Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or betacell hyperplasia in adult patients. J Clin Endocrinol Metab. 2007; 92:1237-1244 PMID: 17227804
    • (2007) J Clin Endocrinol Metab. , vol.92
    • Kauhanen, S.1    Seppänen, M.2    Minn, H.3    Gullichsen, R.4    Salonen, A.5    Alanen, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.